vs

Side-by-side financial comparison of IDACORP INC (IDA) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $360.1M, roughly 1.4× IDACORP INC). IDACORP INC runs the higher net margin — 12.1% vs 6.8%, a 5.3% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -4.2%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -7.2%).

IDACORP, Inc is an electricity holding company, incorporated in Idaho with headquarters in Boise. It comprises Idaho Power Company, IDACORP Financial and Ida-West Energy. It was formed on October 1, 1998.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

IDA vs MD — Head-to-Head

Bigger by revenue
MD
MD
1.4× larger
MD
$493.8M
$360.1M
IDA
Growing faster (revenue YoY)
MD
MD
+2.5% gap
MD
-1.7%
-4.2%
IDA
Higher net margin
IDA
IDA
5.3% more per $
IDA
12.1%
6.8%
MD
Faster 2-yr revenue CAGR
MD
MD
Annualised
MD
-0.1%
-7.2%
IDA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IDA
IDA
MD
MD
Revenue
$360.1M
$493.8M
Net Profit
$43.6M
$33.7M
Gross Margin
Operating Margin
14.9%
9.9%
Net Margin
12.1%
6.8%
Revenue YoY
-4.2%
-1.7%
Net Profit YoY
15.1%
10.5%
EPS (diluted)
$0.78
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDA
IDA
MD
MD
Q4 25
$360.1M
$493.8M
Q3 25
$526.4M
$492.9M
Q2 25
$449.3M
$468.8M
Q1 25
$411.1M
$458.4M
Q4 24
$375.9M
$502.4M
Q3 24
$532.5M
$511.2M
Q2 24
$442.6M
$504.3M
Q1 24
$417.9M
$495.1M
Net Profit
IDA
IDA
MD
MD
Q4 25
$43.6M
$33.7M
Q3 25
$124.4M
$71.7M
Q2 25
$95.8M
$39.3M
Q1 25
$59.6M
$20.7M
Q4 24
$37.9M
$30.5M
Q3 24
$113.6M
$19.4M
Q2 24
$89.5M
$-153.0M
Q1 24
$48.2M
$4.0M
Operating Margin
IDA
IDA
MD
MD
Q4 25
14.9%
9.9%
Q3 25
27.5%
13.8%
Q2 25
22.4%
12.8%
Q1 25
13.4%
7.0%
Q4 24
11.0%
7.8%
Q3 24
25.1%
6.6%
Q2 24
23.3%
-31.3%
Q1 24
11.9%
3.2%
Net Margin
IDA
IDA
MD
MD
Q4 25
12.1%
6.8%
Q3 25
23.6%
14.5%
Q2 25
21.3%
8.4%
Q1 25
14.5%
4.5%
Q4 24
10.1%
6.1%
Q3 24
21.3%
3.8%
Q2 24
20.2%
-30.3%
Q1 24
11.5%
0.8%
EPS (diluted)
IDA
IDA
MD
MD
Q4 25
$0.78
$0.40
Q3 25
$2.26
$0.84
Q2 25
$1.76
$0.46
Q1 25
$1.10
$0.24
Q4 24
$0.72
$0.37
Q3 24
$2.12
$0.23
Q2 24
$1.71
$-1.84
Q1 24
$0.95
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDA
IDA
MD
MD
Cash + ST InvestmentsLiquidity on hand
$215.7M
$375.2M
Total DebtLower is stronger
$3.3B
$570.5M
Stockholders' EquityBook value
$3.6B
$865.9M
Total Assets
$10.2B
$2.2B
Debt / EquityLower = less leverage
0.93×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDA
IDA
MD
MD
Q4 25
$215.7M
$375.2M
Q3 25
$333.2M
$340.1M
Q2 25
$474.5M
$224.7M
Q1 25
$634.5M
$99.0M
Q4 24
$368.9M
$229.9M
Q3 24
$427.9M
$103.8M
Q2 24
$169.6M
$19.4M
Q1 24
$157.6M
$8.0M
Total Debt
IDA
IDA
MD
MD
Q4 25
$3.3B
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$3.1B
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IDA
IDA
MD
MD
Q4 25
$3.6B
$865.9M
Q3 25
$3.5B
$890.7M
Q2 25
$3.4B
$833.8M
Q1 25
$3.3B
$789.2M
Q4 24
$3.3B
$764.9M
Q3 24
$3.3B
$732.5M
Q2 24
$3.2B
$706.5M
Q1 24
$2.9B
$856.2M
Total Assets
IDA
IDA
MD
MD
Q4 25
$10.2B
$2.2B
Q3 25
$10.1B
$2.2B
Q2 25
$9.9B
$2.1B
Q1 25
$9.6B
$2.0B
Q4 24
$9.2B
$2.2B
Q3 24
$9.1B
$2.1B
Q2 24
$8.7B
$2.0B
Q1 24
$8.3B
$2.2B
Debt / Equity
IDA
IDA
MD
MD
Q4 25
0.93×
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.92×
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDA
IDA
MD
MD
Operating Cash FlowLast quarter
$137.8M
$114.1M
Free Cash FlowOCF − Capex
$-216.2M
FCF MarginFCF / Revenue
-60.0%
Capex IntensityCapex / Revenue
98.3%
Cash ConversionOCF / Net Profit
3.16×
3.39×
TTM Free Cash FlowTrailing 4 quarters
$-577.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDA
IDA
MD
MD
Q4 25
$137.8M
$114.1M
Q3 25
$162.8M
$137.3M
Q2 25
$176.9M
$137.2M
Q1 25
$124.3M
$-117.5M
Q4 24
$136.4M
$133.0M
Q3 24
$201.9M
$91.8M
Q2 24
$146.4M
$107.0M
Q1 24
$109.7M
$-125.2M
Free Cash Flow
IDA
IDA
MD
MD
Q4 25
$-216.2M
Q3 25
$-127.9M
Q2 25
$-156.4M
Q1 25
$-77.0M
Q4 24
$-48.9M
Q3 24
$-16.1M
Q2 24
$-199.6M
Q1 24
$-150.3M
FCF Margin
IDA
IDA
MD
MD
Q4 25
-60.0%
Q3 25
-24.3%
Q2 25
-34.8%
Q1 25
-18.7%
Q4 24
-13.0%
Q3 24
-3.0%
Q2 24
-45.1%
Q1 24
-36.0%
Capex Intensity
IDA
IDA
MD
MD
Q4 25
98.3%
Q3 25
55.2%
Q2 25
74.2%
Q1 25
49.0%
Q4 24
49.3%
Q3 24
41.0%
Q2 24
78.2%
Q1 24
62.2%
Cash Conversion
IDA
IDA
MD
MD
Q4 25
3.16×
3.39×
Q3 25
1.31×
1.91×
Q2 25
1.85×
3.49×
Q1 25
2.08×
-5.66×
Q4 24
3.60×
4.36×
Q3 24
1.78×
4.72×
Q2 24
1.63×
Q1 24
2.28×
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IDA
IDA

Retailrevenues$323.0M90%
Transmissionserviceswheeling$18.6M5%
Energyefficiencyprogramrevenues$11.7M3%
Wholesaleenergysales$10.5M3%
Otherrevenues$9.5M3%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons